0 Crore
Total Revenue in FY 2026 (+5% Y-o-Y growth)
FY 2026 demonstrated the underlying strength and resilience of our businesses. Despite a challenging pricing environment, we delivered healthy volume growth across all business segments, reinforcing the depth of customer demand, market share gains, and the competitiveness of our portfolio.
Driven by improved customer relationships, focussed execution, and operational agility, we have built a solid volume foundation that positions us to capture incremental opportunities as market conditions improve.
0 Crore
Total Revenue in FY 2026 (+5% Y-o-Y growth)
Continued volume growth across Pyridine and Fine Chemicals portfolio; CDMO Agro innovator order shipped out
High double digit B3 volume growth in FY 2026
Double digit Acetyls volume and market share gain in Europe